Dualsystems Biotech announces drug profiling agreement with PTC Therapeutics

“As we expand our international client base with a strong focus on North America which presents significant business opportunities, we are particularly pleased to initiate a collaboration in the field of drug profiling with PTC Therapeutics”, said Daniel Auerbach, CEO of Dualsystems Biotech. “We are proud that PTC Therapeutics, a leading biotech company with cutting edge expertise in RNA biology and pioneering novel oral treatments of serious and life threatening diseases, has chosen Dualsystems Biotech as a partner to help uncover molecular targets for their key small molecule drug candidates.” “We are impressed with the innovative screening technology that Dualsystems Biotech has developed over the last ten years” said Joseph Colacino, Ph.D., Vice President of Drug Discovery of PTC Therapeutics. “Dualsystems’ novel screening method has expanded the toolbox to study protein interactions important to the mechanism of action of small molecule drugs. We look forward to utilizing this exciting technology to gain an in depth understanding of the biological activity of key small molecules in our pipeline."

About Dualsystems Biotech AG
Dualsystems Biotech is a CRO located in Zürich, Switzerland with a subsidiary in San Pedro, CA, USA serving the international research community in both academia and the pharmaceutical, biotech, agchem and cosmetic industries. Dualsystems Biotech’s screening platforms enable the identification of small molecule-protein and protein-protein interactions in any cellular setting. Dualsystems Biotech’s innovative drug profiling technologies have significant advantages in cost, speed and sensitivity compared to similar screening technologies for small molecules currently available. They are a powerful tool to accelerate drug discovery and development in the field of mode of action identification, drug repositioning and off-target effect identification in key therapeutic areas, such as oncology and inflammation.

For more information, visit the company’s website at www.dualsystems.com

Copyright © 2011 Dualsystems Biotech AG, All rights reserved.

Our mailing address is: Dualsystems Biotech AG Grabenstrasse 11a 8952 Schlieren